![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η6-p-phenylethacrynate)Cl2(pta)] Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case](https://www.mdpi.com/ijms/ijms-13-13183/article_deploy/html/images/ijms-13-13183f1.png)
glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η6-p-phenylethacrynate)Cl2(pta)] Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case
Dichloro Ru(II) p cymene 1,3,5 triaza 7 phosphaadamantane (RAPTA C): A Case Study ACS Pharmacology & Translational Science Organoruthenium Prodrugs as a New Class of Cholinesterase and GlutathioneSTransferase Inhibitors Ristovski 2018 ChemMedChem Wiley Online Library Combinative Treatment of the PARP Inhibitor Olaparib and Antimetastasis Ruthenium(II)Arene Compound RAPTA T for Triple Negative BRCA1 Wild Type Breast Cancer Cells The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium Based Complexes Frontiers Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
Pay in 4 interest-free payments of $6.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case](https://pubs.acs.org/cms/10.1021/acsptsci.3c00085/asset/images/large/pt3c00085_0003.jpeg)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/4d4f0e01-7368-486c-92ed-1d93de75cf6b/cmdc201800432-toc-0001-m.jpg)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case](https://www.mdpi.com/ijms/ijms-26-10613/article_deploy/html/images/ijms-26-10613-g002-550.jpg)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case](https://www.mdpi.com/molecules/molecules-30-03828/article_deploy/html/images/molecules-30-03828-g004.png)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case](https://www.frontiersin.org/files/Articles/427353/xml-images/fphar-09-01323-g001.webp)